NEW YORK, NY – [February 19, 2025] – Neurobit, a global leader in artificial intelligence-driven healthcare diagnostics, today announced that it has secured a US Utility Patent for its groundbreaking AI system designed to enhance diagnostic efficiency in hospitals and clinics. This innovative technology revolutionizes sleep disorder diagnostics—and is poised to extend its impact to a broad spectrum of healthcare applications—by automating and streamlining the diagnostic process.

Developed to meet the pressing needs of modern healthcare providers, the patented system is deployed via Neurobit PSG—a platform trusted by over 170 global universities and research institutions. By leveraging advanced AI algorithms, the system dramatically reduces diagnostic time while ensuring unparalleled accuracy, empowering hospitals and clinics to deliver faster, more precise care.

Patent Title:
“System and Method for Computer-Implemented Diagnosis of Sleep Disorders”

Patent Summary:
The patented system utilizes cutting-edge artificial intelligence to automate the detection and analysis of sleep disorders. Designed for both clinical and at-home settings, it significantly reduces diagnostic time and variability. Featuring robust encryption for data security and seamless interoperability with existing healthcare infrastructures, the system sets a new standard in precision diagnostics. Its modular framework is adaptable for diverse applications, including neurological and cardiac health, further advancing the integration of AI in healthcare.

Kishan, CEO of Neurobit Inc , stated,
"This patent marks a transformative milestone in our mission to integrate AI into healthcare. By deploying our system through Neurobit PSG, we are equipping hospitals and clinics with a tool that delivers faster, more accurate diagnostics, ultimately enhancing patient outcomes and driving the evolution of precision medicine."

Key Innovations of the Patented System Include:

• AI-Driven Diagnostic Precision: Automates the diagnostic process to minimize human error and variability.

• Enhanced Efficiency: Significantly reduces diagnostic time, streamlining clinical workflows.

• Scalability Across Settings: Versatile design applicable in hospitals, clinics, and home environments.

• Robust Security & Interoperability: Protects patient data with advanced encryption and integrates seamlessly with existing healthcare systems.

• Licensing Through Neurobit PSG: Available for licensing via Neurobit PSG, extending its reach to over 170 global universities and research institutions, and accelerating the adoption of AI across healthcare.

By licensing this technology through Neurobit PSG, clinical and academic institutions can harness a solution that not only boosts diagnostic efficiency but also fosters groundbreaking research in sleep and broader healthcare fields.

For more information about the patented technology and licensing opportunities, please visit https://www.neurobit.com/psg.

About Neurobit

Neurobit is a leading innovator in health analytics, transforming the understanding of sleep as a biomarker to help deliver predictive precision medicine. Their AI-driven solutions offer groundbreaking insights into sleep health and its relation to overall wellbeing. Neurobit's mission is to revolutionize sleep health and analysis with a range of products for healthcare institutions. With a global footprint, Neurobit operates under the name Neurobit Health from its headquarters in New York, USA, while maintaining presences in Bangalore, India as Neurobit Innovations, and in Singapore as Neurobit Technologies.

Learn more at neurobit.com

Media Contact

Neurobit Press
+1 (929) 214-1342
press@neurobit.com

For downloadable high-resolution logos, product images, and other brand assets, please access our dedicated brand assets page at Neurobit Brand Kit.